Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
- Tae Jin Kim, H. Jin, Y. Sung
- Biology, MedicineNature Communications
- 30 October 2014
Findings indicate that the magnitude of systemic polyfunctional CD8 T-cell response is the main contributing factor for histological, cytological and virological responses, providing valuable insights into the design of therapeutic vaccines for effectively treating persistent infections and cancers in humans.
Incidence and Risk Factors of Lower-Extremity Lymphedema After Radical Surgery With or Without Adjuvant Radiotherapy in Patients With FIGO Stage I to Stage IIA Cervical Cancer
- Jin Hwi Kim, J. Choi, S. Hur
- MedicineInternational Journal of Gynecologic Cancer
- 13 December 2011
Adjuvant radiotherapy was significantly associated with development of LEL in women who had undergone radical surgery with lymphadenectomy for FIGO stage I to stage IIA cervical cancer, and patients should be provided with the appropriate preventive education.
The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women.
Clinical significance of human papillomavirus genotyping
- Y. Choi, Jong Sup Park
- BiologyJournal of Gynecologic Oncology
- 1 December 2015
The role of HPV genotyping in cervical cancer is discussed by addressing: clinically important issues in HPV virology; the current application of HPV Genotypes in clinical medicine; and potential future uses for HPV Genotyping.
Probable Nonpapillomavirus Etiology of Squamous Cell Carcinoma of the Vulva in Older Women: A Clinicopathologic Study Using In Situ Hybridization and Polymerase Chain Reaction
- T. Toki, R. Kurman, Jong Sup Park, T. Kessis, R. Daniel, K. Shah
- MedicineInternational Journal of Gynecological Pathology
- 1 April 1991
The data suggest that vulvar cancer has a diverse etiology which in young women in HPv-related but in older women has little association with HPV, and there appears to be a close correlation between the presence of HPV, specivic subsets of invasive carcinomaand VIN, and age.
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary.
- Jin Hwi Kim, Tae Jung Kim, Jong Sup Park
- MedicineJournal of Gynecologic Oncology
- 1 September 2009
Surgical decision-making for BTO based on frozen section diagnosis should be done carefully, especially in large tumors, because over-diagnosis and under- Diagnosis are relatively frequent in frozen proven BTO.
HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
- Yong Seok Lee, C. Rhim, H. Lee, Keun Ho Lee, Jong Sup Park, S. Namkoong
- MedicineGynecologic Oncology
- 1 May 2007
Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature
- E. Ki, Jong Sup Park, Keun Ho Lee, S. Bae, S. Hur
- MedicineWorld Journal of Surgical Oncology
- 15 October 2014
Three patients with large cell neuroendocrine carcinoma of the ovary diagnosed histopathologically were treated postoperatively with combination chemotherapy and the tumor cells were positive for chromogranin A, NSE, CD56, and pancytokeratin.
Asia Oceania Guidelines for the Implementation of Programs for Cervical Cancer Prevention and Control
- H. Ngan, S. Garland, W. Supakarapongkul
- MedicineJournal of Cancer Epidemiology
- 13 April 2011
This paper aims to provide evidence-based recommendations for health professionals to develop a comprehensive cervical cancer program for a clinic, a community, or a country, for high resource and low resource settings.